Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

83
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
83
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.6K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease-specific quality of life after thoracoscopic repair of esophageal atresia: a single-centre cross-sectional study.

Frontiers in pediatrics·2026
Same author

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

NPJ precision oncology·2026
Same author

Near-Infrared Autofluorescence-Guided Parathyroid Identification During Pediatric Thyroidectomy for Thyroid Cancer: A Comparative Study.

Head & neck·2026
Same author

Educational Effects of Training With a Virtual Reality-Based Objective Structured Clinical Examination Software.

Journal of medical education and curricular development·2026
Same author

Endovascular Embolization of Pulmonary Sequestration in Children with Contraindications to Surgery: A Two-Centre Experience with Long-Term Follow-Up.

Children (Basel, Switzerland)·2026
Same author

Atypical case of renovascular hypertension associated with median arcuate ligament syndrome in a paediatric patient.

Urology case reports·2026

Related Experiment Video

Updated: Nov 14, 2025

The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

9.7K

Liver Tumors in Pediatric Patients.

Rebecka Meyers1, Eiso Hiyama2, Piotr Czauderna3

  • 1Division Pediatric Surgery, University of Utah, Primary Children's Hospital, 100 North Mario Capecchi Drive, Suite 3800, Salt Lake City, UT 84113, USA.

Surgical Oncology Clinics of North America
|March 12, 2021
PubMed
Summary

The Pediatric Hepatic International Tumor Trial advances care for children with liver cancer. This global collaboration uses new risk stratification and staging for improved treatment outcomes.

Keywords:
Biliary rhabdomyosarcomaFocal nodular hyperplasiaHepatoblastomaHepatocellular carcinomaInfantile hemangiomaMalignant rhabdoid tumor of the liverMesenchymal hamartomaPRETEXTUndifferentiated embryonal sarcoma of the liver

More Related Videos

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.5K
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

13.6K

Related Experiment Videos

Last Updated: Nov 14, 2025

The Influence of Liver Resection on Intrahepatic Tumor Growth
07:55

The Influence of Liver Resection on Intrahepatic Tumor Growth

Published on: April 9, 2016

9.7K
Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.5K
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

13.6K

Area of Science:

  • Pediatric Oncology
  • Hepatobiliary Malignancies
  • Clinical Trials

Background:

  • Hepatoblastoma and hepatocellular carcinoma are primary liver cancers in children.
  • Previous treatment strategies lacked global standardization.
  • Advances in risk stratification and staging were needed for international collaboration.

Purpose of the Study:

  • To introduce the Pediatric Hepatic International Tumor Trial (PHITT).
  • To describe the collaborative international framework of the PHITT.
  • To highlight the foundational elements enabling this global trial.

Main Methods:

  • The PHITT opened for international enrollment in 2018.
  • It involves pediatric multicenter trial groups from North America, Europe, and the Far East.
  • The trial is supported by a unified global risk stratification system for hepatoblastoma, an international histopathologic consensus classification, and a revised staging system (PRETEXT).

Main Results:

  • The trial represents a significant advancement in pediatric liver cancer care.
  • It facilitates a unified approach to diagnosis and treatment planning.
  • International collaboration is established for pediatric liver tumor research.

Conclusions:

  • The PHITT signifies a new era in managing pediatric liver tumors.
  • Standardized risk stratification and staging are crucial for international cooperative trials.
  • This collaborative effort aims to improve outcomes for children with hepatoblastoma and hepatocellular carcinoma.